Countries China
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
This strategic partnership will enable Fapon to engage in the research, development, manufacturing, and commercialization of PSP raw materials and chemilum...
October 27, 2023 | News
Life Molecular Imaging and Sinotau Gain Regulatory Approval for Neuraceq® in China
Life Molecular Imaging (LMI) and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® (with Chinese trade name 欧韦宁®, florbetaben F-...
October 25, 2023 | News
Bio4t2 Trials CAR-T for Solid Tumors Without Lymphodepletion
The PrismCore platform generates CAR-T that recognizes overexpressed self-antigens on solid tumors. Bio-Engine adapts the CAR-T to transiently recogni...
October 18, 2023 | News
CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China
Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...
October 17, 2023 | News
WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
October 13, 2023 | News
MediLink and BioNTech Partner for Advanced Anti-Cancer Drug
Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...
October 13, 2023 | News
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...
October 10, 2023 | News
Kexing Biopharm Hosts High-end Forum for China-MENA & South Asia Pharma Cooperation in Emerging Markets
MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas business expansion. The event brought together industry experts and he...
October 10, 2023 | News
CANbridge's CAN108 (LIVMARLI®) Receives Approval in Taiwan for ALGS-Related Pruritus
CANbridge Pharmaceuticals Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development ...
October 09, 2023 | News
Innovent Initiates Phase 3 Study of Efdamrofusp Alfa for Age-related Macular Degeneration
nnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...
October 09, 2023 | News
Nortech Systems Suzhou Facility Certified to Produce Class II Medical Devices for Asia Market
“NMPA certification is a major step forward for Nortech Systems and our customers in the region,” said Nortech Systems CEO, Jay D. Miller. &ldq...
October 05, 2023 | News
FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...
October 04, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
